<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000410755"><TermName>PEG-Intron</TermName><TermPronunciation>(… IN-tron)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat hepatitis C infections.  PEG-Intron is a brand name for peginterferon alfa-2b. It is a type of cytokine and a type of biological response modifier.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000732982" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;PEG-Intron&quot;" language="en" id="_3"/><MediaLink ref="CDR0000732981" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;PEG-Intron&quot;" language="es" id="_4"/><SpanishTermName>PEG-Intron</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar infecciones por hepatitis C. PEG-Intron es una marca comercial del peginterferón α-2b. Es un tipo de citocina y un tipo de modificador de la respuesta biológica.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-03-24</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000746606">Peginterferon Alfa-2b</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
